Pharmaceutical Packaging: United States Report

Report Overview

This report forecasts to 2029 US pharmaceutical packaging demand in nominal US dollars at the manufacturer level. Total demand is segmented by product in terms of: bottles and jars, blister packaging, boxes and cartons, prefillable syringes, parenteral vials and ampuls, and other packaging products such as bulk shipping containers, IV containers, and prefillable inhalers.
To illustrate historical trends, total demand and the various segments are provided in annual series from 2019 to 2024.
Pharmaceutical caps and closures, labels, and packaging accessories are excluded unless otherwise stated. For the purposes of this report, pharmaceutical packaging demand is defined as the value of finished packaging products sold by merchant companies and produced or assembled internally by pharmaceutical manufacturers and contract packaging firms. Bulk packaging is also included in the Other segment.
Demand for blister packaging in this report includes not only the blister component itself but also the value of the secondary folding carton, shrink wrap, and other accessories (such as tamper-evident seals or packaging inserts). In other words, it is the cost of a finished package to the drug maker (whether it is produced internally or by contract packaging firms). The blister component of the package is generally not used on its own without secondary packaging. As such, demand for boxes and cartons used in the blister packaging is excluded from secondary packaging data to avoid double counting.
US statistics for pharmaceutical packaging products include sales and production activities in Puerto Rico. Most major multinational drug makers operate one or more production facilities and consume a significant volume of packaging in that territory.
Key macroeconomic indicators are also provided with quantified trends. Other various topics, including profiles of pertinent leading companies, are covered in this report. A full outline of report items by page is available in the Table of Contents.

Related NAICS Codes:

Table of Contents

• Historical Trends
• Key Economic Indicators
• Regulations
• North America Regional Overview

• Products

• Industry Characteristics
• Market Leaders

• Scope
• Sources
• Industry Codes
• Freedonia Methodology
• Resources

• Figure 1 | Key Trends in US Pharmaceutical Packaging Demand, 2025 – 2030
• Figure 2 | US Pharmaceutical Packaging Demand Trends, 2019 – 2025
• Table 1 | Key Indicators for US Pharmaceutical Packaging Demand; 2019, 2025, 2030 (2023US$ bil)
• Figure 3 | North America: Pharmaceutical Packaging Demand Share by Country, 2025 (%)
• Figure 4 | US Pharmaceutical Packaging Demand by Product, 2019, 2025, 2030 (US$ bil)
• Table 2 | US Pharmaceutical Packaging Demand by Product; 2019, 2025, 2030 (US$ mil)
• Figure 5 | US Pharmaceutical Packaging Demand by Product; 2019, 2025, 2030 (%)
• Table 3 | Selected Suppliers to the US Pharmaceutical Packaging Market
• Table 4 | NAICS & SIC Codes Related to Pharmaceutical Packaging
• Table 5 | HS Codes Related to Pharmaceutical Packaging